论文信息 - Trastuzumab Deruxtecan in Anti–Human Epidermal Growth Factor Receptor 2 Treatment–Naive Patients With Human Epidermal Growth Factor Receptor 2–Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial - 字舞流文

Trastuzumab Deruxtecan in Anti–Human Epidermal Growth Factor Receptor 2 Treatment–Naive Patients With Human Epidermal Growth Factor Receptor 2–Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial

Y. Bang | N. Sugimoto | Keun-Wook Lee | D. Sakai | Jeeyun Lee | H. Chung | T. Shimoyama | S. Iwasa | K. Shitara | K. Yamaguchi | H. Kawakami | M. Sugihara | H. Yabusaki | Y. Kawaguchi | T. Kamio | A. Kojima | M. Ryu | K. Saito